South Korea
· Delayed Price · Currency is KRW Bio Port Korea Statistics
Total Valuation
Bio Port Korea has a market cap or net worth of KRW 61.52 billion. The enterprise value is 64.18 billion.
| Market Cap | 61.52B |
| Enterprise Value | 64.18B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Port Korea has 4.43 million shares outstanding. The number of shares has increased by 1.04% in one year.
| Current Share Class | 4.43M |
| Shares Outstanding | 4.43M |
| Shares Change (YoY) | +1.04% |
| Shares Change (QoQ) | +165.79% |
| Owned by Insiders (%) | 44.15% |
| Owned by Institutions (%) | 0.48% |
| Float | 1.74M |
Valuation Ratios
The trailing PE ratio is 9.65 and the forward PE ratio is 10.43.
| PE Ratio | 9.65 |
| Forward PE | 10.43 |
| PS Ratio | 0.84 |
| PB Ratio | 2.15 |
| P/TBV Ratio | 2.15 |
| P/FCF Ratio | 7.25 |
| P/OCF Ratio | 5.09 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.04, with an EV/FCF ratio of 7.56.
| EV / Earnings | 15.61 |
| EV / Sales | 0.88 |
| EV / EBITDA | 9.04 |
| EV / EBIT | 12.25 |
| EV / FCF | 7.56 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.50.
| Current Ratio | 2.03 |
| Quick Ratio | 1.28 |
| Debt / Equity | 0.50 |
| Debt / EBITDA | 2.03 |
| Debt / FCF | 1.70 |
| Interest Coverage | 3.47 |
Financial Efficiency
Return on equity (ROE) is 19.11% and return on invested capital (ROIC) is 8.01%.
| Return on Equity (ROE) | 19.11% |
| Return on Assets (ROA) | 6.75% |
| Return on Invested Capital (ROIC) | 8.01% |
| Return on Capital Employed (ROCE) | 15.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.51 |
| Inventory Turnover | 8.55 |
Taxes
In the past 12 months, Bio Port Korea has paid 1.24 billion in taxes.
| Income Tax | 1.24B |
| Effective Tax Rate | 23.16% |
Stock Price Statistics
The stock price has decreased by -12.90% in the last 52 weeks. The beta is 0.40, so Bio Port Korea's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -12.90% |
| 50-Day Moving Average | 15,559.20 |
| 200-Day Moving Average | 15,112.27 |
| Relative Strength Index (RSI) | 38.93 |
| Average Volume (20 Days) | 67,391 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Port Korea had revenue of KRW 73.35 billion and earned 4.11 billion in profits. Earnings per share was 1,438.99.
| Revenue | 73.35B |
| Gross Profit | 20.94B |
| Operating Income | 5.24B |
| Pretax Income | 5.35B |
| Net Income | 4.11B |
| EBITDA | 7.10B |
| EBIT | 5.24B |
| Earnings Per Share (EPS) | 1,438.99 |
Balance Sheet
The company has 11.76 billion in cash and 14.43 billion in debt, giving a net cash position of -2.67 billion or -601.87 per share.
| Cash & Cash Equivalents | 11.76B |
| Total Debt | 14.43B |
| Net Cash | -2.67B |
| Net Cash Per Share | -601.87 |
| Equity (Book Value) | 28.67B |
| Book Value Per Share | 7,890.82 |
| Working Capital | 14.78B |
Cash Flow
In the last 12 months, operating cash flow was 12.07 billion and capital expenditures -3.58 billion, giving a free cash flow of 8.49 billion.
| Operating Cash Flow | 12.07B |
| Capital Expenditures | -3.58B |
| Free Cash Flow | 8.49B |
| FCF Per Share | 1,917.14 |
Margins
Gross margin is 28.54%, with operating and profit margins of 7.14% and 5.61%.
| Gross Margin | 28.54% |
| Operating Margin | 7.14% |
| Pretax Margin | 7.30% |
| Profit Margin | 5.61% |
| EBITDA Margin | 9.68% |
| EBIT Margin | 7.14% |
| FCF Margin | 11.58% |
Dividends & Yields
Bio Port Korea does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.04% |
| Shareholder Yield | n/a |
| Earnings Yield | 6.68% |
| FCF Yield | 13.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 16, 2025. It was a reverse split with a ratio of 0.1486215.
| Last Split Date | May 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1486215 |
Scores
Bio Port Korea has an Altman Z-Score of 3.16 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.16 |
| Piotroski F-Score | 6 |